Moreover, Hu et al. showed that low CLEC1B expression combined with high PD-L1 expression was associated with poorer clinical outcomes in patients with hepatocellular carcinoma (HCC) 13. The gene discussed is CLEC1B; the disease is hepatocellular carcinoma.